RAC1 and astrocytoma (excluding glioblastoma): In fact, the OS and PFS of patients with high Rac1 scores appeared to be significantly poorer than those with Rac1‐negative tumors, again indicating that Rac1 activity may contribute to the aggressive feature of astrocytomas.